How did Helius Medical's revenue and expenses trend in Q4 2024?

**Helius Medical Technologies Inc. experienced a notable increase in revenue and significant expense pressures in Q4 2024.** 1. **Revenue Growth**: The company's total revenue rose by 13.4% year-over-year, reaching $152,000 compared to $133,000 in the same quarter of the previous year. This growth was primarily driven by the sale of the PoNS System to the VA Healthcare System, which generated $23,844. |code|Ticker|Name|Date|Selling, General, and Administrative Expenses|R&D Expenses|Total Revenue|Advertising and Marketing Expenses|market_code| |---|---|---|---|---|---|---|---|---| |HSDT|HSDT.O|Helius Medical|2024 Q1|2640000|788000|135000||186| |HSDT|HSDT.O|Helius Medical|2024 Q2|2464000|870000|182000||186| |HSDT|HSDT.O|Helius Medical|2024 Q3|2857000|1077000|51000||186| |HSDT|HSDT.O|Helius Medical|2024 Q4|2181000|924000|152000||186| 2. **Expense Pressures**: Despite the revenue growth, Helius Medical faced continued expense challenges. The company reported a quarterly loss of $3.93 million, with an adjusted loss of $1.02 per share. The cost of goods sold stood at $154,000, and the company incurred substantial R&D expenses of $924,000. Additionally, selling, general, and administrative expenses totaled $2.18 million. 3. **Financial Challenges**: Helius Medical Technologies has been navigating financial challenges, including reliance on the VA Healthcare System for sales and facing issues with Medicare reimbursement discussions. The company's cash and cash equivalents decreased to $3.5 million as of September 30, 2024, from $5.2 million at the end of 2023. 4. **Strategic Considerations**: Amid these challenges, Helius Medical has announced the exploration of strategic alternatives to maximize shareholder value. This move is a response to financial constraints and the need to find a viable path forward for the company. In conclusion, while Helius Medical saw a positive revenue trend in Q4 2024, the company continues to grapple with significant expenses and financial challenges. The strategic review announced by the company is a clear indication of the need to address these issues and secure a sustainable future.